Skip to main content

Table 4 Subgroup analysis of individual neuromuscular blocking agents

From: Observational study on patterns of neuromuscular blockade reversal

  

Cases receiving neostigmine

Cases not receiving neostigmine

Neuromuscular blocking agent

Cases receiving NMB

NMB total dose (ED 95 Equivalent)a

Time between last NMB & extubation (minutes)

Total dose of neostigmine (mcg/kg)b

Cases receiving NMB

NMB total dose (ED 95 Equivalent)a

Time between last NMB & extubation (minutes)

N

Median [IQR]

Median [IQR]

Median [IQR]

N

Median [IQR]

Median [IQR]

No Succinylcholine

Atracurium

2981

3.9 [2.6, 5.9]

67.0 [50.0, 90.0]

33.7 [29.7, 41.7]

906

2.9 [2.1, 4.7]

119.0 [85.0, 174.0]

Cisatracurium

12,905

5.6 [3.9, 8.3]

73.0 [53.0, 102.0]

36.0 [30.2, 42.4]

2596

4.6 [3.1, 7.1]

136.0 [90.0, 204.0]

Pancuronium

134

1.3 [0.1, 2.3]

99.5 [62.0, 161.0]

47.2 [35.8, 61.7]

48

0.1 [0.1, 0.1]

210.5 [150.5, 265.0]

Rocuronium

5602

2.8 [2.2, 4.0]

83.0 [59.0, 117.0]

36.6 [29.8, 41.7]

1510

2.4 [1.8, 3.4]

126.0 [89.0, 174.0]

Vecuronium

65,708

3.4 [2.4, 4.9]

76.0 [55.0, 108.0]

38.2 [31.5, 42.2]

7343

2.8 [2.0, 4.5]

145.0 [93.0, 233.0]

Multiple NMBAs

1185

5.9 [4.4, 8.0]

71.0 [52.0, 101.0]

39.0 [32.1, 44.9]

216

6.6 [4.8, 8.6]

92.0 [37.5, 162.5]

Succinylcholine

Atracurium

1407

3.4 [2.2, 5.4]

60.0 [46.0, 84.0]

31.8 [28.2, 39.0]

439

2.5 [1.5, 4.4]

95.0 [65.0, 141.0]

Cisatracurium

4591

4.8 [2.9, 7.6]

65.0 [49.0, 88.0]

32.7 [28.8, 40.0]

864

4.1 [2.2, 7.5]

106.0 [68.0, 153.0]

Pancuronium

63

2.1 [1.2, 2.6]

96.0 [74.0, 140.0]

37.0 [31.6, 48.0]

1025

0.1 [0.1, 0.1]

101.5 [60.0, 181.5]

Rocuronium

674

2.1 [1.3, 3.0]

62.0 [42.0, 87.0]

32.1 [26.1, 39.4]

232

1.0 [0.3, 2.0]

81.0 [53.0, 129.0]

Vecuronium

21,514

3.0 [1.9, 4.7]

67.0 [49.0, 93.0]

36.7 [30.0, 41.3]

3026

2.6 [1.3, 4.8]

115.0 [67.0, 195.0]

Multiple NMBAs

359

3.6 [2.2, 5.6]

65.0 [46.0, 94.0]

35.1 [30.0, 41.3]

305

3.0 [1.5, 6.3]

82.0 [41.0, 154.0]

  1. aOnly among patients with IBW between 40 and 250 kg
  2. bOnly among patients with TBW between 40 and 250 kg